These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 4597976)

  • 1. Percutaneous absorption.
    Brisson P
    Can Med Assoc J; 1974 May; 110(10):1182-5. PubMed ID: 4597976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vehicle effects in percutaneous absorption.
    Idson B
    Drug Metab Rev; 1983; 14(2):207-22. PubMed ID: 6341025
    [No Abstract]   [Full Text] [Related]  

  • 3. Sorption promotors in biopharmaceutics.
    Ritschel WA
    Angew Chem Int Ed Engl; 1969 Oct; 8(10):699-710. PubMed ID: 4982497
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermal lipids and topical drug delivery.
    Hadgraft J; Walters KA; Guy RH
    Semin Dermatol; 1992 Jun; 11(2):139-44. PubMed ID: 1498017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous absorption.
    Idson B
    J Pharm Sci; 1975 Jun; 64(6):901-24. PubMed ID: 1094104
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydration and percutaneous absorption.
    Idson B
    Curr Probl Dermatol; 1978; 7():132-41. PubMed ID: 752449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vehicles based on a sugar surfactant: Colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation.
    Savić SD; Savić MM; Vesić SA; Vuleta GM; Müller-Goymann CC
    Int J Pharm; 2006 Aug; 320(1-2):86-95. PubMed ID: 16730932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
    Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
    Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyoxyethylene fatty acid esters as potential promotors of transdermal absorption for morphine hydrochloride and sulphate.
    Samczewska G; Piechota-Urbańska M; Kołodziejska J
    Polim Med; 2006; 36(2):17-32. PubMed ID: 17022153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of mechanistically defined chemical mixtures (MDCM) to assess component effects on the percutaneous absorption and cutaneous disposition of topically exposed chemicals. I. Studies with parathion mixtures in isolated perfused porcine skin.
    Qiao GL; Brooks JD; Baynes RE; Monteiro-Riviere NA; Williams PL; Riviere JE
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):473-86. PubMed ID: 8975772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiple-pathway model for the diffusion of drugs in skin.
    Lee AJ; King JR; Rogers TG
    IMA J Math Appl Med Biol; 1996 Jun; 13(2):127-50. PubMed ID: 8671583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [About some effects of dimethyl sulfoxide (DMSO) in percutaneous use].
    Kappert A
    Schweiz Med Wochenschr; 1968 Nov; 98(46):1829-37. PubMed ID: 5705674
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vehicles and enhancers on the topical delivery of cyclosporin A.
    Liu H; Li S; Wang Y; Yao H; Zhang Y
    Int J Pharm; 2006 Mar; 311(1-2):182-6. PubMed ID: 16439077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments.
    Henning A; Neumann D; Kostka KH; Lehr CM; Schaefer UF
    Skin Pharmacol Physiol; 2008; 21(2):81-8. PubMed ID: 18187967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Water loss by trans-epidermic route].
    Baker H
    Ann Dermatol Syphiligr (Paris); 1971; 98(3):289-96. PubMed ID: 5124755
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.
    Wester RC; Maibach HI
    Drug Metab Rev; 1983; 14(2):169-205. PubMed ID: 6341024
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin.
    Higaki K; Nakayama K; Suyama T; Amnuaikit C; Ogawara K; Kimura T
    Int J Pharm; 2005 Jan; 288(2):227-33. PubMed ID: 15620862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of surface-active agents in drug absorption.
    Gibaldi M
    Fed Proc; 1970; 29(4):1343-9. PubMed ID: 4990014
    [No Abstract]   [Full Text] [Related]  

  • 20. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
    Panchagnula R; Desu H; Jain A; Khandavilli S
    Farmaco; 2005; 60(11-12):894-9. PubMed ID: 16126203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.